Progesterone in the Menstrual Cycle
The female role in the propagation of the human species includes, of course, the menstrual
cycle. Both sets of ovarian hormones, estrogens and progesterone, are pare of a complex,
interconnected and closely coordinated system of hypothalamic brain centers and pituitary
hormones involving feedback controls designed to produce a wide array of physiological
effects, the purpose of which is to prepare the uterus (and the body as well) for pregnancy
and to produce an ovum ready for fertilization by sperm. Simply put, hypothalamic nuclei
within the limbic brain monitor serum levels of estrogen and progesterone; when levels fall
(bringing on menstruation), the hypothalamic nuclei produces gonadotropin releasing
hormone (GnRH) which causes the pituitary secretion of follicle stimulating hormone
(FSH) which stimulates the ovary to synthesize estrogen which (a) initiates proliferation
of the endometrium, and (b) initiates ovarian follicles to prepare an ovum for ovulation. As
the follicle matures in this activity, pituitary luteinizing hormone (LH) rises to a peak
coinciding with ovulation. With ovulation, the successful ovarian follicle becomes the
corpus luteum which then synthesizes progesterone, often as much as 20-25 mg per day.
Progesterone transforms the proliferative endometrium into the secretory form necessary for
successful implantation of a fertilized ovum, should one occur. If fertilization does not occur
in a week or so, the levels of both ovarian hormones decline, leading to menstruation, and the
cycle begins anew.
In this system, estrogen is the dominant hormone during the first two weeks of the cycle
(prior to ovulation) and, after ovulation, progesterone soon becomes the dominant hormone.
If fertilization does not occur, progesterone declines after day 26 or 27 of the typical
menstrual cycle, bringing on menstruation.
In the event of a successful fertilization of an ovum and its implantation in the uterus,
progesterone secretion by the corpus lelteum is enhanced by a hormone (chorionic
gondotropin) produced by the developing zygote (fertilized ovum). As the placenta
develops, it takes over production of progesterone, increasing the production greatly. During
the third trimester of pregnancy, for example, placental progesterone production reaches 300-
400 mg per day
Interestingly, all the ovarian follicles from which future ova will spring are present in the
ovaries at birth. In fact, there may be 300,000 follicles initially present. With the onset of
puberty (menarche) and the monthly surges of follicle stimulating hormone (FSH) and
luteinizing hormone (LH), the monthly development of ova begins. One would think that the
plentiful initial supply of follicles would yield ova sufficient to last until the cessation of
menstrual cycles (menopause) at age 50-55. This, however, is not the case in North America.
It has become quite common that unusual follicle “burn-out” occurs as early as age 35 and
thus many women have anovulatory (and thus, lacking progesterone) cycles for 15 years or
more before actual menopause. This results in sustained monthly estrogen dominance,
leading to a wide variety of medical problems stemming from unopposed estrogen side
effects. Such women present with water retention, increased fat deposition about the hips
and lower abdomen, hypertension, lack of libido, irritability and depression, fibrocystic
breasts, endometrial cancer and breast cancer
Since these complaints are far less common in “undeveloped” countries, it is natural to
speculate that the cause of follicle burn-out is environmental, probably a toxic contaminant to
which we are exposed, or possibly some dietary deficiency. The leading candidates for this
endemic malady at this time are our pervasive petrochemical derivatives, principally the
petrochemically derived insecticides and herbicides which, being fat-soluble, become
concentrated in animal fat food chain products. Many of these compounds act as estrogen
mimics and, in this regard are amazingly potent, being active at nanogram (one-billionth
[109
] of a gram) levels. They include pesticides such as DDT, DDE, Kepone, dieldrin,
dicofol, and methoxychlor; and polychlorinated biphenyls (PCB’s), anthracene, alkyl phenols
and bisphenol A (the monomer that is condensed to make polycarbonate plastic). These estrogen mimics are highly lipophilic (fat soluble), very persistent (not biodegradable or well
excreted), and accumulate in fat tissue of animals and humans over a lifetime. 1,2
The toxicity of DDT was recognized sometime ago and its use has been severely restricted
in the US and European countries. However, it is still being used in third world countries,
especially for mosquito control, and new DDT production plants are still being funded by the
World Bank. The DDT does not remain in the country where it is used. It, or its metabolite,
DDE, can be carried by the wind to incorporation in the food chain of all sea life, including
the fish we eat; and its use on food crops becomes international when the foods are sold
worldwide. The other pesticides, PCB’s, and plastics are particularly prevalent in our society
today and the full panoply of their toxic results is yet to be revealed.
Thus, it should be clear that anovulatory cycles, whether created by environmental toxins
or other causes, lead to progesterone deficiency and estrogen dominance, with all its potential
for undesirable side effects. When this hormone imbalance is present, supplementation with
natural progesterone is paramount